AU2003204708A1 - Inhibition of Raf Kinase using Substituted Heterocyclic Ureas - Google Patents

Inhibition of Raf Kinase using Substituted Heterocyclic Ureas

Info

Publication number
AU2003204708A1
AU2003204708A1 AU2003204708A AU2003204708A AU2003204708A1 AU 2003204708 A1 AU2003204708 A1 AU 2003204708A1 AU 2003204708 A AU2003204708 A AU 2003204708A AU 2003204708 A AU2003204708 A AU 2003204708A AU 2003204708 A1 AU2003204708 A1 AU 2003204708A1
Authority
AU
Australia
Prior art keywords
inhibition
substituted heterocyclic
raf kinase
heterocyclic ureas
ureas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2003204708A
Other versions
AU2003204708B2 (en
Inventor
Jacques Dumas
Holia Hatoum-Mokdad
Jeffrey Johnson
Uday Khire
Wendy Lee
Timothy Bruno Lowinger
Holger Paulsen
Aniko Redman
Bernd Riedl
William J. Scott
Roger A. Smith
Jill E. Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Healthcare LLC
Original Assignee
Bayer Healthcare LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU21989/99A external-priority patent/AU2198999A/en
Application filed by Bayer Healthcare LLC filed Critical Bayer Healthcare LLC
Priority to AU2003204708A priority Critical patent/AU2003204708B2/en
Priority claimed from AU2003204708A external-priority patent/AU2003204708B2/en
Publication of AU2003204708A1 publication Critical patent/AU2003204708A1/en
Priority to AU2006201959A priority patent/AU2006201959B2/en
Application granted granted Critical
Publication of AU2003204708B2 publication Critical patent/AU2003204708B2/en
Assigned to BAYER HEALTHCARE LLC reassignment BAYER HEALTHCARE LLC Request for Assignment Assignors: BAYER CORPORATION
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2003204708A 1997-12-22 2003-06-13 Inhibition of Raf Kinase using Substituted Heterocyclic Ureas Ceased AU2003204708B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2003204708A AU2003204708B2 (en) 1997-12-22 2003-06-13 Inhibition of Raf Kinase using Substituted Heterocyclic Ureas
AU2006201959A AU2006201959B2 (en) 1997-12-22 2006-05-11 Inhibition of Raf Kinase using Substituted Heterocyclic Ureas

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08996343 1997-12-22
AU21989/99A AU2198999A (en) 1997-12-22 1998-12-22 Inhibition of raf kinase using substituted heterocyclic ureas
PCT/US1998/026078 WO1999032106A1 (en) 1997-12-22 1998-12-22 Inhibition of raf kinase using substituted heterocyclic ureas
AU2003204708A AU2003204708B2 (en) 1997-12-22 2003-06-13 Inhibition of Raf Kinase using Substituted Heterocyclic Ureas

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU21989/99A Division AU2198999A (en) 1997-12-22 1998-12-22 Inhibition of raf kinase using substituted heterocyclic ureas

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2006201959A Division AU2006201959B2 (en) 1997-12-22 2006-05-11 Inhibition of Raf Kinase using Substituted Heterocyclic Ureas

Publications (2)

Publication Number Publication Date
AU2003204708A1 true AU2003204708A1 (en) 2003-07-17
AU2003204708B2 AU2003204708B2 (en) 2006-05-25

Family

ID=39338634

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003204708A Ceased AU2003204708B2 (en) 1997-12-22 2003-06-13 Inhibition of Raf Kinase using Substituted Heterocyclic Ureas

Country Status (1)

Country Link
AU (1) AU2003204708B2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1401825E (en) 2001-06-11 2009-10-23 Virochem Pharma Inc Thiophene derivatives as antiviral agents for flavivirus infection
US8329924B2 (en) 2001-06-11 2012-12-11 Vertex Pharmaceuticals (Canada) Incorporated Compounds and methods for the treatment or prevention of Flavivirus infections
ES2345438T3 (en) 2002-12-10 2010-09-23 Virochem Pharma Inc. COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF INFECTIONS BY FLAVIVIRUS.
KR20090086081A (en) 2006-11-15 2009-08-10 바이로켐 파마 인코포레이티드 Thiophene analogues for the treatment or prevention of flavivirus infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2616099B2 (en) * 1990-02-27 1997-06-04 三菱電機株式会社 Wire electric discharge machine
US5185358A (en) * 1991-06-24 1993-02-09 Warner-Lambert Co. 3-heteroatom containing urea and thiourea ACAT inhibitors
JPH11503110A (en) * 1995-02-17 1999-03-23 スミスクライン・ビーチャム・コーポレイション IL-8 receptor antagonist
EP0986382B1 (en) * 1997-05-23 2008-06-25 Bayer Pharmaceuticals Corporation Raf kinase inhibitors

Similar Documents

Publication Publication Date Title
HUP0004426A3 (en) Inhibition of raf kinase using aryl and heteroaryl substituted heterocyclic ureas
PL331856A1 (en) Heterocyclic inhibitors of metaloprotease
AU4956297A (en) Raf kinase inhibitors
PL338259A1 (en) Novel spiroazabicyclic heterocyclic compounds
HK1034907A1 (en) Heterocyclic inhibitors of p38
AP9600805A0 (en) Heterocyclic ring-fused pyrimidine derivatives
AU3363599A (en) Heterocyclic families of compounds for the modulation of tyrosine protein kinase
IL132170A0 (en) Novel heterocyclic compounds
AU7548298A (en) Nitrogenous heterocyclic compounds and hyperlipemia remedy containing the same
GB9715892D0 (en) Heterocyclic compounds
AU3039995A (en) Heterocyclic derivatives of N-phenylamides
AU7907498A (en) Novel heterocyclic compounds
PL322722A1 (en) Novel heterocyclic compounds
AUPP003197A0 (en) New heterocyclic compounds
AU7907298A (en) Novel heterocyclic compounds
IL138247A0 (en) Substituted bisindolymaleimides for the inhibition of cell proliferation
AU3075595A (en) Anti-helicobacter heterocyclic derivatives of azolones
AU6291098A (en) Novel heterocyclic compounds
PL341306A1 (en) Herbicidal derivatives of 3-(benzazol-4-lyl) pyrimidinone
AU2003204708A1 (en) Inhibition of Raf Kinase using Substituted Heterocyclic Ureas
AUPO622597A0 (en) New heterocyclic compounds
AUPO527597A0 (en) Novel heterocyclic compounds
SI1047418T1 (en) Inhibition of raf kinase using substituted heterocyclic ureas
IL117813A0 (en) Use of heterocyclic compounds
SI1056725T1 (en) Inhibition of raf kinase using aryl and heteroaryl substituted heterocyclic ureas